Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

02/20/2023 | Health News

Results of pharmacokinetic analysis show Omomyc mini-protein maintains its structural integrity in tumor tissue for at least 72
Source: Read Full Article

Related Posts